Pharma

Bengaluru: Britain’s Indivior PLC fell by more than 20% on Friday after the US Food and Drug Administration (FDA) approved the first generic versions of Suboxone Film, an opioid addiction treatment that generates 80% of its revenue. Dr Reddy’s Laboratories received FDA approval for a copy-cat version of the treatment, which has been rapidly losing market share due to...

New Delhi: The quality cloud over the Halol plant of Sun Pharmaceutical Industries Ltd has lifted, with the company stating that all the issues raised by the US Food and Drug Administration (FDA) have been satisfactorily resolved. “Sun Pharmaceutical Industries has received the establishment inspection report (EIR) from the US FDA for the inspection conducted at its Halol facility...

Is this the beginning of something good for Sun Pharmaceutical Industries Ltd? More importantly, will investors regain their long lost faith in the company, whose shares have halved from their high levels of April 2015? Consider the 8% jump in its share price on Friday. News reports said the US Food and Drug Administration had delivered a voluntary action indicated...

Mumbai, May, 2018: Huhtamaki-PPL Webtech Division partic ipated in the recent InnoPack Pharma Confex held in Mumbai on 24th and 25th May, 2018.  This event focuses on various aspects of pharmaceuticals packaging.   The well designed Huhtamaki-PPL Webtech Stand attracted a large number of visitors as it displayed a comprehensive range of products including paper labels, film...

New Delhi: Shares of Sun Pharmaceutical Industries Ltd on Monday rose over 7% after the company reported its first profit growth in six quarters, helped by lower material costs and a one time tax write back. In intraday trading, Sun Pharma shares rose 8.17% to Rs504.70 apiece on BSE. On NSE, shares of the company advanced by 6.54% to...